urlscan.io logo urlscan.io
SecurityTrails logo

www.pharmavoice.com Open in urlscan Pro
2606:4700::6812:e64  Public Scan

Back to summary
Submitted URL: https://link.pharmavoice.com/click/29049485.6/aHR0cHM6Ly93d3cucGhhcm1hdm9pY2UuY29tLw/630b945799d236bfa10fc4eeC52afe7c7
Effective URL: https://www.pharmavoice.com/?utm_source=Sailthru&utm_medium=email&utm_campaign=PharmaVoice%2017%20Days%20Disengaged%202022-0...
Submission: On September 14 via manual from US — Scanned from DE

Form analysis 5 forms found in the DOM

GET /search/

<form action="/search/" method="GET">
  <label for="search-desktop">
    <span class="screen-reader-text search">Search</span>
  </label>
  <input id="search-desktop" type="Search" name="q" placeholder="search">
  <button type="submit" value="" class="analytics t-search-navigation-drawer">
    <img src="/static/images/proformative_search_glass_black.svg?231516061021" width="18" height="18" loading="lazy">
  </button>
  <img class="close" src="/static/img/menu_icons/close.svg?273117231121" width="16" height="16" loading="lazy">
</form>

Name: signup — POST /signup/

<form class="form js-form-email-validate" name="signup" action="/signup/" method="POST">
  <label for="id_657183_email" class="email-input js-email-input">
    <span class="screen-reader-text">Email:</span>
    <input type="email" name="email" placeholder="Work email address" class="email" required="" id="id_657183_email">
  </label>
  <input type="hidden" name="signup_box_location" value="sidebar">
  <input type="hidden" name="signup_initial_url_path" value="/">
  <input type="hidden" name="js_enabled" value="1" id="id_657183_js_enabled">
  <ul class="signup-list list-no-bullets">
    <li>
      <label><span class="screen-reader-text">Select user consent:</span></label>
      <input type="checkbox" name="user_consent" id="id_user_consent-sidebar" value="1" class="checkbox">
      <label for="id_user_consent-sidebar">
        <span class="signup-user-consent_box">
          <span> By signing up to receive our newsletter, you agree to our <a href="https://www.industrydive.com/terms-of-use/" target="_blank">Terms of Use</a> and
            <a href="https://www.industrydive.com/privacy-policy/" target="_blank">Privacy Policy</a>. You can unsubscribe at anytime. </span>
        </span>
      </label>
    </li>
  </ul>
  <button class="button button--medium signup-button" type="submit" value="Sign up">Sign up</button>
  <label class="error email_error" style="display:none;">A valid email address is required.</label>
  <label class="error newsletter-error" style="display:none;">Please select at least one newsletter.</label>
</form>

Name: signup — POST /signup/

<form class="form js-form-email-validate" name="signup" action="/signup/" method="POST">
  <label for="id_50dc49_email" class="email-input js-email-input">
    <span class="screen-reader-text">Email:</span>
    <input type="email" name="email" placeholder="Work email address" class="email" required="" id="id_50dc49_email">
  </label>
  <input type="hidden" name="signup_box_location" value="bottom">
  <input type="hidden" name="signup_initial_url_path" value="/">
  <input type="hidden" name="js_enabled" value="1" id="id_50dc49_js_enabled">
  <ul class="signup-list list-no-bullets">
    <li>
      <label><span class="screen-reader-text">Select user consent:</span></label>
      <input type="checkbox" name="user_consent" id="id_user_consent-bottom" value="1" class="checkbox">
      <label for="id_user_consent-bottom">
        <span class="signup-user-consent_box">
          <span> By signing up to receive our newsletter, you agree to our <a href="https://www.industrydive.com/terms-of-use/" target="_blank">Terms of Use</a> and
            <a href="https://www.industrydive.com/privacy-policy/" target="_blank">Privacy Policy</a>. You can unsubscribe at anytime. </span>
        </span>
      </label>
    </li>
  </ul>
  <button class="button button--medium signup-button" type="submit" value="Sign up">Sign up</button>
  <label class="error email_error" style="display:none;">A valid email address is required.</label>
  <label class="error newsletter-error" style="display:none;">Please select at least one newsletter.</label>
</form>

GET /search/

<form action="/search/" method="GET" data-ajax="false">
  <label for="search-mobile">
    <span class="screen-reader-text">Search</span>
    <input id="search-mobile" type="search" name="q" placeholder="Search" data-role="none">
  </label>
  <button type="submit" value="" data-role="none" class="analytics t-search-navigation-mobile">
    <img src="/static/img/menu_icons/search.svg?320116291121" width="15" height="15" alt="search">
  </button>
</form>

Name: signup — POST /signup/

<form class="form js-form-email-validate" name="signup" action="/signup/" method="POST">
  <label for="id_dfacfa_email" class="email-input js-email-input">
    <span class="screen-reader-text">Email:</span>
    <input type="email" name="email" placeholder="Work email address" class="email" required="" id="id_dfacfa_email">
  </label>
  <input type="hidden" name="signup_box_location" value="integrated_menu">
  <input type="hidden" name="signup_initial_url_path" value="/">
  <input type="hidden" name="js_enabled" value="1" id="id_dfacfa_js_enabled">
  <ul class="signup-list list-no-bullets">
    <li>
      <label><span class="screen-reader-text">Select user consent:</span></label>
      <input type="checkbox" name="user_consent" id="id_user_consent-integrated_menu" value="1" class="checkbox">
      <label for="id_user_consent-integrated_menu">
        <span class="signup-user-consent_box">
          <span> By signing up to receive our newsletter, you agree to our <a href="https://www.industrydive.com/terms-of-use/" target="_blank">Terms of Use</a> and
            <a href="https://www.industrydive.com/privacy-policy/" target="_blank">Privacy Policy</a>. You can unsubscribe at anytime. </span>
        </span>
      </label>
    </li>
  </ul>
  <button class="button button--medium signup-button" type="submit" value="Sign up">Sign up</button>
  <label class="error email_error" style="display:none;">A valid email address is required.</label>
  <label class="error newsletter-error" style="display:none;">Please select at least one newsletter.</label>
</form>

Text Content

Skip to main content

CONTINUE TO SITE ➞


 * Voices
   * Q&A
   * Profiles
   * Women of the Week Podcast
   * Opinions
 * Topics
   * Biotech
   * Commercialization
   * Leadership
   * Manufacturing
   * Patient
   * Pharma
   * Policy & Regulation
   * Research & Development
 * Library
 * Events
 * PharmaVoice 100
   * 2022 PV100
   * Red Jacket Award
   * RSVP
   * 2021 PV100

Menu
 * Search
 * Sign up

Search

Diego Camargo/PharmaVoice
Podcast


WOMAN OF THE WEEK: AGILENT TECHNOLOGIES’ DR. KATHARINE KNOBIL

As the first chief medical officer of the diagnostic testing company, Dr.
Katharine Knobil is focused on moving the science forward beyond precision
oncology to liquid biopsy. Read more ➔


TOP STORIES


 1. FEDS COULD SOON BRING COVID-STYLE FIGHT TO SUPERBUG THREAT


 2. FROM THE ‘GO-GO DAYS’ TO A BUBBLE CRUNCH — THE BIOTECH SECTOR FACES ITS NEXT
    CHALLENGE

 3. Profile // PharmaVoice 100
    
    
    TECH WIZARDS: DR. RICH CHRISTIE

 4. Profile // PharmaVoice 100
    
    
    DE&I CHAMPIONS: DR. PAM DIAMOND

 5. Profile // PharmaVoice 100
    
    
    INNOVATORS: DR. JULA INRIG


THE LATEST

 * 

 * Illustration: Matthieu Bourel for Industry Dive
   
   PharmaVoice 100
   
   
   THE 2022 PHARMAVOICE 100
   
   From standout executives to R&D pioneers — this year’s class of honorees is
   defining the next era of leadership.
   
   PharmaVoice 100

 * Ground+Picture/shutterstock.com/
   
   Sponsored by GoodRx
   
   
   MEDICATION AFFORDABILITY’S IMPACT ON ADHERENCE AND OUTCOMES
   
   Improved patient affordability is an important lever that can increase
   adherence, which in turn can improve health outcomes.
   
   Patient
 * Permission granted by John Tsai
   Profile // PharmaVoice 100
   
   
   INNOVATORS: DR. JOHN TSAI
   
   How the former president of global drug development and chief medical officer
   at Novartis funneled his curiosity for engineering into a bold new approach
   to drug development.
   
   PharmaVoice 100
 * Permission granted by Dr. Barbara Wirostko
   Profile // PharmaVoice 100
   
   
   ENTREPRENEURS: DR. BARBARA WIROSTKO
   
   Qlaris Bio’s CMO and co-founder has her sights on bringing life-changing
   treatments to patients with debilitating eye diseases.
   
   PharmaVoice 100
 * 
 * Iryna Imago via Getty Images
   
   
   DRUG RECALLS ARE TICKING UPWARDS — HERE’S HOW TO AVOID COSTLY PITFALLS
   
   Supply chain challenges, labor shortages and increased FDA inspections are
   boosting recall risks — but careful planning can keep companies in the clear.
   
   Pharma
 * Permission granted by Dr. Tania Small
   Profile // PharmaVoice 100
   
   
   DISRUPTERS: DR. TANIA SMALL
   
   GSK’s medical oncology head is paving the way for patient-driven drug
   development and more equitable care.
   
   PharmaVoice 100
 * Permission granted by Dr. Steven Steinhubl
   Profile // PharmaVoice 100
   
   
   LEGACY LEADERS: DR. STEVEN STEINHUBL
   
   The chief medical officer at physIQ is working at the intersection of
   healthcare, clinical trials and technology to deliver better, faster and more
   accurate treatments to patients around the globe.
   
   PharmaVoice 100
 * Permission granted by Fahti Khosrowshahi
   Profile // PharmaVoice 100
   
   
   DISRUPTERS: FAHTI KHOSROWSHAHI
   
   The president, CEO and founder of Ceek Women’s Health is on a mission to
   upend the OBGYN market.
   
   PharmaVoice 100
 * 
 * Permission granted by Rafael Amado
   Profile // PharmaVoice 100
   
   
   INNOVATORS: DR. RAFAEL AMADO
   
   Quiet, supportive and collaborative leadership have made the R&D leader a
   standout innovator for Allogene Therapeutics.
   
   PharmaVoice 100
 * Permission granted by Maureen Hennessey
   Profile // PharmaVoice 100
   
   
   DE&I CHAMPIONS: MAUREEN HENNESSEY
   
   The senior vice president, director of value transformation at PRECISIONvalue
   is moving the needle on patient nonadherence challenges.
   
   PharmaVoice 100
 * Artur Plawgo via Getty Images
   
   
   PHARMA’S RENEWED SICKLE CELL INVESTMENT LIFTS A ONCE-SHIRKED DISEASE
   
   Pfizer’s $5.4 billion deal to acquire Global Blood Therapeutics invigorated
   the fast-growing market, and patients are fit to be the benefactors.
   
   Biotech
 * Permission granted by Dr. Jeremy Levin
   Profile // PharmaVoice 100
   
   
   LEGACY LEADERS: DR. JEREMY LEVIN
   
   Over his 30-year career, the founder, chairman and CEO of Ovid Therapeutics
   has demonstrated that he is a patient advocate, scientist, clinician and
   innovator at heart.
   
   PharmaVoice 100
 * Permission granted by Abigail Jenkins
   Profile // PharmaVoice 100
   
   
   DISRUPTERS: ABIGAIL JENKINS
   
   With the belief that empathy is critical to leadership, the former chief
   commercial and business officer of Lyndra Therapeutics has a strong track
   record of building teams and accelerating progress.
   
   PharmaVoice 100
 * Permission granted by Raymond Stevens
   Profile // PharmaVoice 100
   
   
   LEGACY LEADERS: RAYMOND STEVENS
   
   The longtime pioneer in new drug discovery methods and founder of Structure
   Therapeutics has leveraged innovative science for commercial success.
   
   PharmaVoice 100
 * Permission granted by Dr. Helen Thackray
   Profile // PharmaVoice 100
   
   
   LEGACY LEADERS: DR. HELEN THACKRAY
   
   The chief research and development officer at BioCryst Pharmaceuticals is
   leaning into decades of experience to advance a promising pipeline of rare
   disease products.
   
   PharmaVoice 100
 * Permission granted by Armon Sharei
   Profile // PharmaVoice 100
   
   
   ENTREPRENEURS: ARMON SHAREI
   
   The CEO of SQZ Biotech is leveraging a technology platform that is simple in
   its design yet targeted at making cell therapy to break down barriers to the
   treatments.
   
   PharmaVoice 100
 * Diego Camargo/PharmaVoice
   Podcast
   
   
   WOMAN OF THE WEEK: FORESITE CAPITAL’S CINDY MESAROS
   
   The longtime marketing pro details her fascinating career journey and how
   she’s positioning early stage health companies to thrive. 
   
   Biotech
 * Permission granted by Jeff Fischer
   Profile // PharmaVoice 100
   
   
   ENTREPRENEURS: JEFF FISCHER
   
   The co-founder and president led Longhorn Vaccines and Diagnostics to an
   unprecedented surge in production of its testing tech at the height of
   COVID-19 and is now pursuing a universal flu vaccine.
   
   PharmaVoice 100
 * Permission granted by Dr. Jane Barlow
   Profile // PharmaVoice 100
   
   
   DISRUPTERS: DR. JANE BARLOW
   
   The executive vice president and chief clinical officer of Real Endpoints is
   boosting patient access to innovative therapies through value-based payer
   agreements.
   
   PharmaVoice 100
 * Permission granted by Matt Clark
   Profile // PharmaVoice 100
   
   
   TECH WIZARDS: MATT CLARK
   
   X-Chem’s CEO has pioneered DNA-encoded libraries to revolutionize small
   molecule discovery.
   
   PharmaVoice 100
 * Permission granted by Adrelia Allen
   Profile // PharmaVoice 100
   
   
   DE&I CHAMPIONS: ADRELIA ALLEN
   
   Merck & Co.’s senior director of clinical trial patient diversity is
   transforming the pharma giant’s approach to inclusion and equality.
   
   PharmaVoice 100
 * Permission granted by Frank Lee
   Profile // PharmaVoice 100
   
   
   LEGACY LEADERS: FRANK LEE
   
   At Forma Therapeutics, the CEO and president is placing patients in
   leadership roles to weave patient centricity into the company’s business and
   development model.
   
   PharmaVoice 100
 * Permission granted by Shanthi Ganeshan
   Profile // PharmaVoice 100
   
   
   INNOVATORS: SHANTHI GANESHAN
   
   The longtime regulatory pro has used innovative strategies to deliver
   emerging oncology therapies to patients from her position as head of
   regulatory affairs at Stemline.
   
   PharmaVoice 100
 * joel-t via Getty Images
   
   
   FIRST 90 DAYS: ADAPTIVE BIOTECH’S TYCHO PETERSON
   
   A long-time analyst, Tycho Peterson brings his business savvy to the C-suite
   at Adaptive, where he began as CFO in June with a knowledge of what works and
   what doesn’t in the diagnostics space.
   
   Biotech
 * Gabriel Kuchta via Getty Images
   
   
   MODERNA’S LAWSUIT AGAINST PFIZER AND BIONTECH EXPLAINED IN 10 QUOTES
   
   The biotech says that its competitors’ COVID-19 vaccine copied proprietary
   mRNA technology. Here’s a breakdown of the case.
   
   Biotech
 * Diego Camargo/PharmaVoice
   Podcast
   
   
   WOMAN OF THE WEEK: THREAD’S KIM BOERICKE
   
   Fresh off an eight-year tour of duty at ICON, the CRO industry veteran is
   stepping into a new role and a new title as chief delivery officer at Thread.
   
   Leadership




GET THE FREE NEWSLETTER

Subscribe to PharmaVoice for important stories, insights & perspectives

Email:
 * Select user consent: By signing up to receive our newsletter, you agree to
   our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Sign up A valid email address is required. Please select at least one
newsletter.

Podcast
Woman of the Week: Agilent Technologies’ Dr. Katharine Knobil
As the first chief medical officer of the diagnostic testing company, Dr.
Katharine Knobil is focused on moving the science forward beyond precision
oncology to liquid biopsy.


MOST POPULAR

 1. Feds could soon bring COVID-style fight to superbug threat
 2. From the ‘go-go days’ to a bubble crunch — the biotech sector faces its next
    challenge
 3. Parexel joins pharmacy giants in quest to boost community health clinical
    trials
 4. The ‘long COVID’ nightmare: Data-driven alliance offers understanding of the
    lasting viral impact


LIBRARY RESOURCES

 * Trendline
   The latest developments in oncology research
 * Playbook
   Fast-Track Insights & Cut Costs with Curated Omics Data Custom content for
   QIAGEN
 * Webinar - on demand
   Addressing Personalized Medicine’s Complexity Problem: Examples from
   Parkinson’s Disease Custom content for Rho

View all


COMPANY ANNOUNCEMENTS

 * Azzur Group Appoints Life Sciences Leader, Adri Osman, as Vice President of
   Corporate Quality … From Azzur Group LLC
 * RxMx and Curatio Announce Merger to Tackle Urgent Health Care Gaps From RxPx
 * Annual PharmaVoice 100 honorees celebrated in Sept. 15 virtual event From
   PharmaVoice
 * Hope Alexander, Global Manufacturing Facilities Development Leader, Joins
   Burns & McDonnell From Burns & McDonnell

View all | Post a press release


EVENTS

 * 15 SEP
   Virtual Event | 10 a.m. ET PharmaVoice 100: The Next Era of Leadership
   Presented by PharmaVoice
 * 01 NOV
   Virtual Event | 2 p.m. ET Building a biotech in a turbulent market Presented
   by Industry Dive


INDUSTRY INTEL

 * Data That Informs and Performs: Accelerating Evidence Into Action Whitepaper
   • Provided by Premier Health
 * The use of AI for evidence generation from healthcare literature Blog Post
 * Tailored, Dedicated Support Expedites COVID-19 Vaccine Trial Whitepaper •
   Provided by WCG




PHARMAVOICE STORIES AND INSIGHTS DELIVERED TO YOUR INBOX

Get the free daily newsletter read by industry leaders

Email:
 * Select user consent: By signing up to receive our newsletter, you agree to
   our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Sign up A valid email address is required. Please select at least one
newsletter.


--------------------------------------------------------------------------------

 * 
 * 
 * 
 * 

EXPLORE

 * About
 * Editorial Team
 * Contact Us
 * Newsletter
 * Article Reprints
 * Press Releases
 * What We’re Reading

REACH OUR AUDIENCE

 * Advertising
 * Post a press release



--------------------------------------------------------------------------------

© 2022 Industry Dive. All rights reserved. | View our other publications |
Privacy policy | Terms of use | Take down policy.
Cookie Preferences / Do Not Sell
Search
 * Home
 * Voices
   * Q&A
   * Profiles
   * Women of the Week Podcast
   * Opinions
 * Topics
   * Biotech
   * Commercialization
   * Leadership
   * Manufacturing
   * Patient
   * Pharma
   * Policy & Regulation
   * Research & Development
 * Library
 * Events
 * PharmaVoice 100
   * 2022 PV100
   * Red Jacket Award
   * RSVP
   * 2021 PV100


GET PHARMAVOICE IN YOUR INBOX

The free newsletter covering the top industry headlines

Email:
 * Select user consent: By signing up to receive our newsletter, you agree to
   our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Sign up A valid email address is required. Please select at least one
newsletter.